GeminIQ Website Logo

Viewing BTMD free

Subscribe for full history, 50+ metrics, screener, watchlist...

biote Corp.

BTMD

Companies in Medicinal Chemicals & Botanical Products

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Common Class B
-----------0
Common Class A
0031-313100-3342069
Assets
Cash And Cash Equivalents At Carrying Value
52428204239382679896668
Assets Current
Assets Current
3655575069687062114122118112
Short Term Investments
----------2020
Accounts Receivable Net Current
7789888887108
Inventory Net
20191612131516191917117
Prepaid Expense And Other Assets Current
4559667899118
Property Plant And Equipment Net
1111101087652111
Capitalized Computer Software Net
553444555556
Goodwill
666666666---
Intangible Assets Net Excluding Goodwill
445556666---
Operating Lease Right Of Use Asset
333333122222
Deferred Income Tax Assets Net
2425272828296825252318
Other Assets Noncurrent
000000------
Assets
8910811110512312210193160155150139
Liabilities And Stockhold…
Accounts Payable Current
874436464467
Accrued Liabilities Current
1010119101187108105
Liabilities Current
Liabilities Current
284556514852474624222522
Long Term Debt Current
666666666666
Contract With Customer Liability Current
333333333332
Derivative Liabilities Current
-----0001---
Operating Lease Liability Current
111111000000
Long Term Debt Noncurrent
94969798100101103104105107108109
Long Term Line Of Credit
55----------
Contract With Customer Liability Noncurrent
111112221111
Operating Lease Liability Noncurrent
222333122222
Other Liabilities Noncurrent
000--2------
Derivative Liabilities Noncurrent
2458617162453414664
Liabilities
137158177184208225228235205192201212
Additional Paid In Capital
000000000000
Stockholders Equity
Retained Earnings Accumulated Deficit
-46-50-64-79-84-100-125-138-32-29-41-46
Stockholders Equity
-48-50-65-79-90-102-127-143-36-37-51-73
Accumulated Other Comprehensive Income Loss Net Of…
-0-0-0-0-0-0-0-0-0-0-0-0
Treasury Stock Value
-10-9-9-6-6-6-6-6-4---
Minority Interest
88765442-9-7-11-27
Liabilities And Stockholders Equity
8910811110512312210193160155150139
Common Class V
505-5500-242929-6-6
Preferred Stock Par Or Stated Value Per Share
000000000000
Preferred Stock Shares Authorized
101010101010101010101010
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20265.88%-1.81%----------
2025-13.50%5.00%8.00%19.44%3.82%0.35%-0.18%-1.11%-18.45%13.57%56.43%42.86%
20248.82%22.06%30.56%14.39%3.28%-6.56%16.49%12.32%-7.79%-12.50%-7.45%-7.98%
2023-3.72%14.38%18.10%-11.76%-8.73%-8.91%12.81%-4.55%-18.60%-14.91%-13.02%-3.62%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
1.29
1.22
1.01
0.98
1.42
1.32
1.50
1.34
4.75
5.51
4.69
5.16
Quick Ratio
0.45
0.69
0.64
0.57
1.02
0.91
1.00
0.74
3.61
4.31
3.82
4.45
Working Capital
8.13M
9.68M
815.00K
-1.03M
20.21M
16.61M
23.47M
15.50M
90.30M
100.13M
92.67M
90.38M
Leverage & Debt
Debt to Equity
-2.86
-3.14
-2.70
-2.33
-2.45
-2.20
-1.80
-1.66
-4.57
-5.25
-3.92
-2.90
Interest Coverage TTM
2.89
3.24
2.69
2.83
2.52
2.87
3.69
4.07
4.89
4.50
5.11
4.96
Debt Ratio
1.54
1.47
1.59
1.75
1.69
1.84
2.25
2.52
1.28
1.24
1.34
1.53
Efficiency & Turnover
Asset Turnover TTM
1.77
1.67
1.84
2.01
1.41
1.42
1.54
1.61
1.34
1.39
1.42
1.42
Days Sales Outstanding TTM
14.71
13.77
15.36
15.38
14.45
13.36
17.65
15.63
15.26
13.54
17.65
15.32
Receivables Turnover TTM
24.82
26.51
23.76
23.73
25.26
27.31
20.68
23.35
23.91
26.95
20.68
23.82
Per Share Metrics
Diluted EPS TTM
0.57
0.86
0.81
1.04
0.53
0.00
-0.19
0.03
-0.05
-0.11
0.01
-0.94
Free Cash Flow Per Share TTM
0.94
0.96
1.10
1.10
1.17
1.13
1.12
0.62
0.58
1.02
0.84
1.55
Dividend Per Share TTM
0.05
0.06
0.05
0.07
0.17
0.14
0.19
0.19
0.16
0.34
0.33
0.52
Margin Metrics
Gross Profit Margin TTM
70.12%
71.46%
72.37%
71.97%
71.27%
70.52%
69.91%
69.56%
69.33%
68.78%
67.80%
67.62%
Operating Profit Margin TTM
15.43%
18.50%
16.09%
17.79%
15.49%
16.03%
17.79%
15.90%
16.66%
15.46%
16.54%
16.99%
Net Profit Margin TTM
10.92%
16.44%
15.13%
16.60%
9.78%
0.02%
-3.10%
0.53%
-0.92%
-1.51%
0.10%
-10.77%
Growth Metrics
Net Revenue Growth (1Y)
-5.63%
-2.52%
1.34%
6.32%
6.44%
6.38%
4.84%
3.70%
8.49%
12.37%
-2.85%
-1.42%
Net Income Growth (1Y)
5.46%
68,589.13%
-594.69%
3,201.00%
-1,229.20%
-101.64%
-3,257.48%
-105.15%
-80.71%
189.47%
-78.55%
-603.07%
EPS Growth (1Y)
8.35%
75,148.97%
-590.16%
3,352.00%
-1,341.65%
-101.23%
-3,185.17%
-103.22%
-90.20%
81.49%
-89.25%
-468.07%
Valuation Metrics
P/E TTM
2.01
2.57
3.18
3.85
5.38
4,604.21
-28.95
246.80
-116.34
-45.28
819.51
-7.20
P/B TTM
-0.86
-1.61
-1.44
-1.61
-1.24
-2.07
-1.37
-1.75
-4.48
-3.48
-3.03
-1.91
P/S TTM
0.22
0.42
0.48
0.64
0.53
1.07
0.90
1.32
1.07
0.69
0.84
0.78
Market Cap
41.37M
81.34M
94.00M
127.13M
104.85M
211.79M
173.23M
247.05M
200.80M
127.00M
155.31M
139.96M
Enterprise Value
136.73M
159.25M
169.33M
212.27M
169.24M
279.90M
243.81M
330.79M
233.54M
150.88M
203.98M
187.09M
Calculated Values
Free Cash Flow TTM
28.88M
30.18M
34.39M
34.82M
36.98M
38.81M
34.91M
20.62M
19.94M
26.21M
25.46M
32.14M
Net Debt
95.36M
77.91M
75.33M
85.14M
64.40M
68.11M
70.57M
83.74M
32.73M
23.88M
48.67M
47.12M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2025-05-07Purchase
Owner: Barrera, Richard R, Rb Ma…
Title: -
Shares: 11,677
Price/Share: $3.35
Value: $39,117.95
Shares Owned: 4,622,748
Relationship: TenPercentOwner
Ownership: Indirect
2025-04-30Purchase
Owner: Rb, Management Gp Llc, Ro…
Title: -
Shares: 1,933
Price/Share: $3.30
Value: $6,378.90
Shares Owned: 4,175,034
Relationship: TenPercentOwner
Ownership: Indirect
2025-04-21Purchase
Owner: Barrera, Richard R, Royst…
Title: -
Shares: 8,801
Price/Share: $3.27
Value: $28,779.27
Shares Owned: 4,173,101
Relationship: TenPercentOwner
Ownership: Indirect
2025-04-17Purchase
Owner: Guines, Llc, Rb Managemen…
Title: -
Shares: 6,874
Price/Share: $3.29
Value: $22,615.46
Shares Owned: 4,164,300
Relationship: TenPercentOwner
Ownership: Indirect
2025-04-09Purchase
Owner: Guines, Llc, Barrera Rich…
Title: -
Shares: 13,532
Price/Share: $3.21
Value: $43,437.72
Shares Owned: 4,156,426
Relationship: TenPercentOwner
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
47.17%
Inst. Shares: 14,454,806
Shares Outstanding: 30,646,356
2025-12-31
47.75%
Inst. Shares: 14,938,770
Shares Outstanding: 31,283,245
2025-09-30
47.32%
Inst. Shares: 14,826,473
Shares Outstanding: 31,331,973
2025-06-30
50.93%
Inst. Shares: 16,107,443
Shares Outstanding: 31,625,485
2025-03-31
51.14%
Inst. Shares: 16,100,326
Shares Outstanding: 31,485,777

biote Corp. (BTMD) — SEC Financial Statements & Analysis

biote Corp. (BTMD) is a medicinal chemicals & botanical products company. biote Corp. trades on BTMD: Nasdaq as: BTMD. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), biote Corp. reported a -5.63% year-over-year revenue growth, a Gross Profit Margin of 70.12% (TTM), a Debt-to-Equity ratio of -2.86x, a Price-to-Sales (P/S) ratio of 0.22x (TTM), a Price-to-Book (P/B) ratio of -0.86 (TTM), at a market cap of $41.37M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-5.63%
Gross Profit Margin TTM
70.12%
Debt To Equity
-2.86x
P/S TTM
0.22x
P/B TTM
-0.86
Market Cap
$41.37M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is biote Corp. in?

biote Corp. (BTMD) operates in the Medicinal Chemicals & Botanical Products industry.

What is BTMD's market cap?

biote Corp. (BTMD) has a market capitalization of $41.37M as of 2026-03-31.

What is BTMD's P/E ratio?

biote Corp. (BTMD)'s trailing twelve month P/E ratio is 2.01x as of 2026-03-31.

What exchange does BTMD trade on?

biote Corp. (BTMD) trades on the BTMD: Nasdaq.

Research Faster.
Invest Smarter.

biote Corp. (BTMD) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.